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1. Abstract
In Xenopus laevis, corticotropin-releasing factor (CRF) and Urocortin 1 (Ucn1) are 
present in the brain and they both are potent stimulators of a-melanophore-stimulating 
hormone (aMSH) secretion by melanotrope cells in the pituitary gland. Since in mammals 
and Xenopus laevis both CRF and Ucn1 bind with high affinity to CRF receptor type 1 
(CRFi), one of the purposes of this study was to identify the sites of action of CRF and Ucn1 
in the Xenopus brain and pituitary gland. Moreover, we raised the hypothesis that the external 
light intensity is a physiological condition controlling CRF1 expression in the pituitary 
melanotrope cells. By in situ hybridisation we have demonstrated the presence of CRF1 
mRNA in the olfactory bulb, amygdala, nucleus accumbens, preoptic area, ventral habenular 
nuclei, ventromedial thalamic area, suprachiasmatic nucleus, ventral hypothalamic area, 
posterior tuberculum, tectum mesencephali and cerebellum. In the pituitary gland, CRF1 
mRNA occurs in the intermediate and distal lobe. The optical density of the CRF1 mRNA 
hybridisation signal in the intermediate lobe of the pituitary gland is 59.4% stronger in white- 
adapted animals than in black-adapted ones, supporting our hypothesis that the environmental 
light condition controls CRF1 mRNA expression in melanotrope cells of X. laevis, a 
mechanism likely responsible for CRF- and/or Ucn1-stimulated secretion of aMSH.
2
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In the mammalian central nervous system (CNS), corticotropin-releasing factor (CRF)
1
2
3
4
5 2. Introduction
6
7
8
9
10
11 [1] and other members of the CRF-family of peptides, such as the urocortins (Ucn) 1, 2 and 3
12
13 [2-8] mediate various physiological, behavioural and immune responses to stressful
14
15 challenges [e.g. 9-18]. The actions of CRF and Ucn are mediated by two G-protein-coupled
16
17 receptors designated CRF-receptor 1 (CRF1) and CRF-receptor 2 (CRF2) [19,20], which have
18
19 been localised in the brain by in situ hybridisation and receptor autoradiography [21-24].
20
21 CRF1 is most abundant in the pituitary intermediate and anterior lobe [22,23], olfactory-
22
23 related structures, amygdala, cerebral cortex, brainstem sensory relay nuclei and cerebellum,
24
25 whereas CRF2 has a more restricted distribution, being present in the posterior lobe of the
26
27 pituitary, in subcortical structures and, most prominently, in the lateral septal nucleus,
28
29 hypothalamus and amygdala [23].
30
31 The present study is concerned with the sites of action of CRF and CRF-like peptides in
32
33 the amphibian brain and pituitary gland. Molecular cloning studies in the South African
34
35 clawed toad Xenopus laevis showed a CRF-like gene, which encodes for a protein with 93%
36
37 homology with rat and human CRF [25], whereas Xenopus Ucn1 reveals about 70%
38
40 homology with mammalian Ucn1 [26]. CRF is widely distributed in the X. laevis brain, with
41
42
43
44
4546 nucleus, locus ceruleus and nucleus motorius nervi trigemini [27,28]. In contrast to CRF,
47
48 Ucn1 shows a more limited distribution in the X. laevis brain, occurring in the magnocellular
49
50 nucleus (Mg), Edinger-Westphal nucleus (EW), nucleus posteroventralis tegmenti, central
51
52 grey and nucleus motorius nervi trigemini [28]. In the pituitary gland, CRF-ir fibres are
53
54 scarce, whereas many strongly stained Ucn1-ir fibres occur in the pars nervosa [28].
55
56 The functions of CRF and Ucn1 in amphibians are less well investigated than in
57
58 mammals, but CRF in the Mg, the amphibian homologue of the mammalian paraventricular
59
60 and supraoptic nuclei, exerts its ‘traditional’ role as controller of the hypothalamo- 
hypophyseal-adrenal axis [27,29-31], and both CRF and Ucn1 in the Mg may be involved in
main CRF-immunoreactive (ir) sites in the nucleus accumbens, nucleus habenularis ventralis, 
magnocellular nucleus, paraventricular organ, tectum mesencephali, anterior tegmental
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the control of feeding-related processes [26,32,33]. Most interesting are the roles of CRF and 
Ucn1 in the regulation of the neuroendocrine melanotrope cells in the intermediate lobe of 
the amphibian pituitary gland, a regulation up to now unknown in mammals. Amphibian 
melanotropes release a-melanophore-stimulating hormone (aMSH), a processing product of 
proopiomelanocortin (POMC), which is responsible for skin darkening during the process of 
background adaptation [e.g. 34,35]. In X. laevis CRF-like peptides, including Xenopus Ucn1, 
stimulate the production of POMC and the secretion of aMSH [28,36,37]. The mechanism(s) 
by which amphibian CRF and Ucn1 exert these actions are only fragmentary known. In X. 
laevis, two types of CRF receptor, CRF1 and CRF2, have been identified in both the brain and 
the pituitary gland, using RT-PCR. Both receptors share ca. 80% amino acid sequence 
homology with their mammalian counterparts, CRF1 binds with high affinity to both CRF and 
Ucn1, whereas CRF2has a higher affinity for Ucn1 than for CRF [38-41].
The present study focuses on CRF1, and aims to identify the possible sites by which 
CRF and Ucn1 act on this receptor in the brain and pituitary gland of Xenopus laevis. 
Moreover, in view of the dependence of melanotrope secretory activity in this animal on the 
external light condition, we hypothesised that this light condition is a physiological factor 
controlling the expression of melanotrope cell CRF1. We have assessed the presence of this 
receptor by in situ hybridisation of CRF1 mRNA, and then we determined if this expression in 
the intermediate pituitary lobe depends on the state of the background light condition (black 
vs. white).
3. Materials and Methods
3.1. Animals
Ten young-adult specimens of Xenopus laevis, aged 6 months, with a body weight of 
28-32 g, were raised in our Nijmegen laboratory under constant illumination, at a water 
temperature of 22 ± 1°C, and fed weekly on ground beef heart (Janssen, Nijmegen, The 
Netherlands) and Trouvit trout pellets (Trouvit, Trouw, Putten, The Netherlands). Before the 
experiments, animals had been adapted to either a black (n=5) or a white (n=5) background,
4
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3.2. Tissue preparation for in situ hybridisation
(MS222; Novartis, Basel, Switzerland) in tap water, and transcardially perfused with ice-cold 
0.6% sodium chloride, for 5 min. Then they were perfused with 250 ml ice-cold Bouin’s
1
2
3
4 for three weeks. Animal treatment was in agreement with the Declaration of Helsinki and the
5
6 Dutch law concerning animal welfare, as tested by the ethical committee for animal
7
8 experimentation of Radboud University Nijmegen.
9
10
11
12
13
15 Toads were deeply anaesthetised by immersion in 0.1% tricaine methane sulfonate
16
17
18
19
2021 fixative, for 15 min. After decapitation, the brain and pituitary gland were quickly dissected
22
23 and postfixed in the same fixative, for 16 h at 4°C, washed in 70% ethanol for 24 h, to
24
25 eliminate excess of picric acid, dehydrated in a graded ethanol series, and embedded in
26
27 paraffin. Coronal serial sections (7 ^m) were mounted on poly-L-lysine-coated slides (Sigma
28
29 Chemical, St Louis, MO, USA) and allowed to air-dry, for 16 h at 45°C, deparaffinised and
30
31 rehydrated. Brain sections of black-adapted (BA) and white-adapted (WA) animals were
32
33 processed in parallel for in situ hybridisation for Xenopus CRF1 mRNA.
34
35
36
37 3.3. In situ hybridisation
38
39 A Greenstar labelled probe was used (GeneDetect, Auckland, New Zealand) and a 3’-
40
41 digoxigenin (DIG)-labelled antisense oligonucleotide probe was synthesised to hybridise with
42
43 the Xenopus CRF1. The CRF1 probe was a synthetic antisense oligonucleotide corresponding
44
45 to bases 264-311
46
47 (TCCTGGCATTGAGCGTAGTCTCCTCTCCCAGCCCAGCTGCCGTTCAGG, 48 mer) of
49 the cDNA sequence of Xenopus CRF1 [38] (Genbank accession no. Y14036). Starting from
50
51
52
53
54
55
56
57
58 with the basic local alignment search tool (BLAST) [42] did not reveal any homology or
59
60 similarity of our probes with other X. laevis genes. After deparaffination, sections were rinsed 
in autoclaved 0.1 M sodium phosphate-buffered saline (PBS; pH 7.4) for 10 min, and
the same bases, a sense oligonucleotide probe
(CCTGAACGGCAGCTGGGCTGGGAGAGGAGACTACGCTCAATGCCAGGA, 48 mer) 
was synthesised for specificity control tests with in situ hybridisation. Computer analysis
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postfixed in 4% paraformaldehyde in 0.1 M sodium phosphate buffer (PB; pH 7.4), for 5 min 
at 20°C. After rinsing the sections in PBS for 10 min, acetylation was performed with 0.25% 
acetic acid anhydride in 0.1 M tri-ethanolamine buffer (pH 8.0), for 10 min, followed by 
rinsing in 2 times concentrated (X2) standard saline citrate buffer (SSC; pH 7.0), for 3 min. 
Sections were then treated with 0.1% pepsin (Sigma Chemical) in 0.2 N HCl, at 37°C for 15 
min, followed by 2 x 5 min wash in PBS and subsequently incubated in hybridisation mixture 
containing 4 ml X20 SSC, 10 ml deionised formamide, Denhardt’s solution, 10% dextran 
sulfate, 0.25 mg/ml tRNA, 2 ml 1M DTT and 2 ml autoclaved MQ, for 2 h at 37°C. After 
rinsing in X2 SSC for 5 min, sections were incubated in hybridisation mixture with the 3’- 
DIG-labelled anti sense/sense oligonucleotide probe (ca. 100 ng/ml), for 16 h at 37°C, 
followed by a quick rinse in SSC containing 1M DTT, at room temperature. Then, sections 
were stringently washed twice in X1 and X0.5 SSC containing 1M DTT (Roche, Basel, 
Switzerland), for 15 min at 55°C, and in SSC, for 10 min at 20°C. DIG label was visualised 
by the alkaline phosphatase (AP) method with nitro-bluetetrazoliumchloride/5-bromo-4- 
chloro-3-indolyl phosphate-toluidine salt (NBT/BCIP; Roche) as a substrate. In brief, after 3 
x 5 min rinses in 0.1 M Tris-buffered saline (TBS; pH 7.5) sections were washed in TBS 
containing 1% of blocking agent (TBS-BA; Roche), for 30 min, followed by incubation in 
sheep-anti-DIG-AP (1:200; Roche) in TBS-BA, for 4 h at 20°C. Sections were then rinsed 3 
x 5 min in TBS followed by a 5 min wash in TBS buffer containing 0.05M MgCl2 (TBS-M; 
pH 9.5), and after 48 h incubation hybridisation was visualised in TBS-M containing 
NBT/BCIP. The reaction was stopped by several rinses in tap water followed by rinses in 
distilled water. Sections were then mounted in Kaiser’s glycerol gelatine (Merck, Darmstadt, 
Germany) and examined using a Leica DMRBE microscope (Leica Microsystems, 
Heerbrugg, Switzerland).
3.4. Morphometry and statistical analysis
Digital images of 5 WA and 5 BA toads were taken using the Leica DMRBE optical 
system with a Leica DC 500 digital camera (Leica Microsystems) and a x20 objective lens, 
and analysed with Scion Image software (version 3.0b; NIH, Bethesda, MD, USA). In situ
6
Page 7 of 29 Journal of Neuroendocrinology
4. Results
1
2
3
4 hybridisation staining intensity was determined in three 7 ^m sagittal sections per animal, in
5
6 the middle of (a) the internal granule cell layer of the olfactory bulb, (b) the intermediate
7
8 pituitary and (c) the distal pituitary lobe. Values were expressed as means of the optical
9
10 density (OD) ± standard error of the mean (SEM). Means per adaptation state were analysed
11
12 with analysis of variance (a=5%), using Statistica (StatSoft, Tulsa, OK, USA), after testing
14 for homogeneity of variance (Bartlett’s test) [43] and normality [44].15
16
17
18
19
20
21
2223 4 1 . Distribution of CRF1 mRNA in the brain and pituitary gland
24
25 With the anti-sense mRNA probe, CRF1 mRNA hybridisation signals were seen
26
27 throughout the brain in the neuronal perikarya, with variable staining intensities, whereas the
28
29 neuronal cell nucleus, axons, axon terminals and other elements in the brain like glial cells,
30
31 and blood vessels are devoid of signal (Fig. 1a). The absence of any background staining and
32
33 of staining with the sense probe (control) (Fig. 1b), indicates that the signal specifically
34
35 reveals the presence of CRF1 mRNA. The occurrence of the CRF1 mRNA hybridisation
36
37 signal in a brain structure was further studied in serial sagittal sections (Fig. 2) and the
38
39 different hybridisation intensities, assessed by visual observation and semiquantitatively
40
41 expressed as ‘low’, ‘moderate’ and ‘strong’, are summarised in Table 1. The detailed
42
43 distribution of CRF1 mRNA is as follows.
44
45 In the telencephalon, the most rostral perikarya expressing CRF1 mRNA are situated in
46
47 the olfactory bulb (Fig. 2), where the internal granule cell layer surrounding the lateral
48
49 ventricle shows a strong signal (Fig. 3a). In the latero-dorsal and latero-ventral pallium, cells
50
51
52
53
54
55
56
57
58 expression levels of CRF1 mRNA (Fig. 3c).
59
60 In the diencephalon, a rostral group of neurones showing moderate hybridisation signals 
is situated in the anterior preoptic area of the hypothalamus (Figs. 2,3d). A low expression
are moderately stained, whereas in the mitral cell layer and post-olfactory eminence no signal 
was observed. In the nucleus accumbens a moderate expression signal is present (Fig. 3b), 
whereas in the medial and lateral part of the amygdala scattered cells were found with low
7
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signal occurs in small cell group in the dorsal and ventral habenular nuclei. No signal was 
detected in the Mg. More caudally, moderate expression of CRF1 mRNA occurs in cells 
scattered in the suprachiasmatic nucleus (Fig. 3d) and in the parallel cell layers of the 
ventromedial thalamic nucleus (Fig. 3e). In the posterior tubercle some slightly stained cells 
are present, whereas in the infundibular area, strong CRF1 mRNA staining is shown by the 
ventral hypothalamic nucleus (Fig. 3f).
In the dorsal mesencephalon, several piriform cell layers of the optic tectum reveal 
hybridisation signals with varying intensities, ranging from moderate in the internal layers to 
strong in the external layers 5 and 6 (Fig. 3g).
In the rhombencephalon, strong CRF1 mRNA expression was encountered in the 
cerebellum (Fig. 3h).
Pituitary gland. In the pars nervosa of the pituitary lobe no hybridisation signal was 
observed (Figs. 2,4a), but strong staining is present in the melanotrope cells of the 
intermediate lobe (Fig. 4b,d). In the distal lobe, a moderate to strong CRF1 mRNA expression 
signal occurs in a rostral cluster of endocrine cells. In view of their position, they most likely 
are corticotrope cells (Fig. 4e).
Differences between CRF1 mRNA expression as a result of different adaptation states 
are dealt with in the next paragraph.
4.2 Effect o f background adaptation on the expression o f CRF1 mRNA
In order to determine whether and to what extent the expression of CRF1 mRNA in 
pituitary melanotrope cells is physiologically regulated by the background light condition, we 
measured mRNA hybridisation intensities in WA (n=5) and BA (n=5) X. laevis, and 
expressed them as optical density (OD) in arbitrary units. As controls we studied two other 
structures of which we had found (see above, Fig. 2, and Table 1) that they are rich in CRF1 
mRNA but which are not known to be involved in the process of background light 
adaptation: the internal granule cell layer of the olfactory bulb (igl) and the presumed 
corticotrope cells in the distal lobe.
As can be readily seen at low magnification (Fig. 4a,b) the intermediate lobe of the
8
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all cells are stained with the same, rather weak intensity (Fig. 4a,c). No effect of background 
light intensity on the expression of CRFi in the brain was noted.
1
2
3
4 pituitary gland in BA animals is much larger than in WA toads, which is due to hyperplasia
5
6 of the melanotrope cells, which are the only endocrine cells in the intermediate lobe [45]. On
7
8 the other hand, the intensity of the CRF1 mRNA hybridisation signal in the intermediate lobe
9
10 of WA animals is much higher than in BA animals (Fig. 4b,d). A special observation is that
11
12 in WA animals, the intensity of the hybridisation signal differs among individual melanotrope
14 cells, being moderate in some cells, but strong or even very strong in others. In BA animals15
16
17
18
19
2021 This stimulatory effect of white background adaptation on, specifically, the expression
22
23 of CRF1 mRNA in the melanotrope cells, clearly appears from the morphometric study. In
24
25 both the igl and in the distal lobe, the OD of the CRF1 mRNA hybridisation signal does not
26
27 differ between BA and WA animals (Fig. 5) but the melanotrope cells in the intermediate
28
29 pituitary lobe of WA animals show a 59.4% higher OD than melanotropes of BA animals
30
31 (P<0.05; Fig. 5).
32
33
34
35
36
37 5. Discussion
38
39
40 5.1. Technical considerations
41
42 With in situ hybridisation, using a DIG-labelled oligonucleotide probe, we here
45 describe for the first time the detailed distribution of mRNA encoding CRF1 in the brain and
46
47
48
49
5051 1) the higher stability (resistance to RNAse degradation) when compared to a RNA probe, 2)
52
53 the small molecular size of the oligonucleotide, which provides better tissue penetration, and
54
55 3) the fact that oligonucleotides do not self-hybridise.
56
57
58 5.2. Comparison o f CRF1 mRNA distribution in the brain o f amphibians with mammals
59
60 The general existence of CRF1 in the brain of X. laevis was previously assumed on the 
basis of RT-PCR [38,41], but no information was available regarding the brain structures
in the pituitary gland of a non-mammalian vertebrate, the South African clawed toad X. 
laevis. The reasons for using an oligonucleotide probe instead of a ribonucleotide probe are:
9
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expressing this receptor. This is the first report describing the presence of CRF1 mRNA, and 
hence, most probably, of CRF1, in the telencephalon, diencephalon and brainstem of X.
laevis.
The distribution of the CRF1 mRNA in the Xenopus brain appears to be substantially 
less extensive than that of CRF1 mRNA in the mammalian brain. For example, in the rat 
telencephalon, CRF1 mRNA occurs in the peri glomerular layer, mitral layer and olfactory 
tubercle as well as in the hippocampus, diagonal band of Broca and bed nucleus of the stria 
terminalis [23], all regions that in X. laevis are devoid of CRF1 mRNA. In the rat 
di encephalon CRF1 mRNA is present in many thalamic areas such as the latero-dorsal and 
latero-posterior nucleus and the lateral geniculate nucleus, whereas in Xenopus only the 
ventromedial thalamic nucleus shows CRF1 mRNA expression. CRF1 mRNA has been 
observed furthermore in the rat brainstem, viz. in many sensory relay structures, whereas in 
the toad only the tectum mesencephali and the cerebellum reveal CRF1 mRNA hybridisation. 
The wider distribution of this receptor mRNA in the rat suggests that its ligands CRF and 
Ucn1 have acquired novel central functions during evolution.
On the other hand, the distributions of CRF1 mRNA in the brain of X. laevis and of 
mammals show some clear similarities. In X. laevis, going from rostral to caudal, strong 
CRF1 hybridisation signals occur in the internal granule cell layer of the olfactory bulb, the 
ventral hypothalamic area, the tectum mesencephali and the cerebellum. The homologous 
nuclei in the rat brain, viz. the granule cell layer of the olfactory region, the arcuate nucleus, 
the superior colliculus and the granule layer of the cerebellum, respectively, also express 
CRF1 signals [23]. Furthermore, nor in the Mg of X. laevis nor in its rat homologue, the PVN, 
any CRF1 mRNA signal has been observed [23]. These similarities between CRF1 locations 
in Xenopus and rat indicate that the presence/absence and functions of this receptor type are 
strongly evolutionary conserved.
5.3. Relation between CRF1 mRNA and CRF/Ucn1 peptide distributions
The in situ hybridisation signal for CRF1 mRNA is a strong indication for the local 
existence of CRF1 protein. Because in vitro studies showed that both Xenopus CRF and Ucn1
10
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1
2
3
4 bind with high affinity to Xenopus CRFi [41], it is of functional interest to assess if the CRFi
5
6 mRNA expressions described in this study match with the descriptions of CRF- and Ucni-ir
7
8 fibres and perikarya [27,28]. Table 1 lists our present description of CRF1 mRNA distribution
9
10 in Xenopus, as well as literature data on the distribution of CRF and Ucnl peptides in this
11
12 animal [27,28]. As the table shows, both CRF- and Ucnl-ir elements occur in the olfactory
14 bulb, nucleus accumbens, posterior tubercle and tectum mesencephali, suggesting that in15
1617 these four areas both CRF and Ucnl can act on CRF1. However, in most brain structures
CRF1 mRNA coexists with CRF-ir fibres only, which fact supports the notion that CRF is the1819
2021 endogenous ligand for CRF1, and that Ucn1 binds preferably to CRF2 [26,38]. In the nucleus
22
23 habenularis ventralis, CRF1 mRNA expression occurs in CRF-ir perikarya. Here,
24
25 ultrastructural studies may be helpful to determine if the same cells both release CRF and
26
27 possess CRF1, which would point to an autocrine action of CRF.
28
29 These data together, support the idea that CRF and Ucn1 act on CRF1 receptors in the
30
31 Xenopus brain. Whether the absence of CRF1 mRNA in CRF- and/or Ucn1-peptide
32
33 containing brain structures points to actions of these ligands on CRF2, or on an action of
34
35 these ligands in other areas of the brain that are reached by volume transmission or via axons,
36
37 that cannot be revealed at the light microscope level, remains to be established.
38
39
40
41 5.4. Physiological regulation o f CRF1 mRNA expression in the amphibian intermediate
42
43 pituitary lobe
45 We here demonstrate for the first time that CRF1 occurs in the intermediate lobe of
46
47 the pituitary gland of a non-mammalian species. The presence of CRF1 in the intermediate
50 lobe of X. laevis extends the previous general demonstration by RT-PCR of this receptor type
51
52
53
54
55
56
57
58 vitro superfusion studies that both peptides stimulate the release of aMSH from melanotrope
59
60 cells [28,37]. We now show an upregulation of CRF1 mRNA in WA toads, as compared to 
BA animals. This receptor upregulation is specific for the melanotrope cells, as no effect of
in the total pituitary gland [38], as it shows that CRF1 is restricted to the melanotrope cells of 
the intermediate lobe. Recently, we showed the presence of CRF and Ucn1 peptides in the 
median eminence and in the pars nervosa of the pituitary lobe of Xenopus and revealed by in
11
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the background illumination state was visible in the igl or in the distal pituitary lobe. Our 
demonstration of CRF1 mRNA in the intermediate lobe fits in with the fact that the Mg, 
projecting to neurohemal areas in the median eminence and the pituitary pars nervosa, is 
controlling melanotrope cell secretory activity via the release of CRF and Ucn1, both 
peptides stimulating a-MSH release in vitro [28,37]. Interestingly, in WA the strength of the 
CRF1 mRNA signal is not homogenous throughout the gland, suggesting that some cells are 
producing more receptors than others. This result supports the notion that the intermediate 
lobe of the pituitary gland is composed of a heterogeneous cell population as to size [45] and 
POMC production [46].
Up to now, it is not known what factors control the release of CRF and Ucn1 release 
from the pituitary pars nervosa. In the present study we show that adaptation of Xenopus to a 
white background upregulates the expression of CRF1 mRNA. This finding suggests that in 
these WA animals, melanotropes become highly sensitive to CRF and Ucn1 so that when 
placed on a black background, their high receptor density enables the cells to rapidly mobilise 
stored a-MSH to the secretory process. In this way, the animals can turn black quickly, 
permitting fast camouflage. Indeed, in line with these results, Verburg-van Kemenade et al. 
[37] reported that ovine CRF evokes stronger in vitro aMSH release from neurointermediate 
lobes of WA than of BA toads. For X. laevis melanotropes a similar situation has been 
described with respect to thyrotropin-releasing hormone-receptor type 3 mRNA, and for NPY 
Y1 receptor mRNA, which are both upregulated in WA animals [47,48]. Like CRF and 
Ucn1, TRH simulates a-MSH release, whereas NPY inhibits this release [49,50].
Further studies on the dynamics of the Mg and the in vivo conditions by which the 
activity of this nucleus is regulated, as well as on the possible presence and regulation of 
CRF2 receptors in the pituitary gland, may elucidate the plastic interactions between CRF and 
Ucn1 and their receptors that are crucial to the functioning of the neuroendocrine reflex 
mechanism by which melanotrope cells in amphibians control the process of skin colour 
adaptation to background illumination. We propose that this mechanism is an example of 
neuroendocrine plasticity crucial to adaptation processes in general and to adaptation to 
stressful environmental events in particular.
12
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Legends
Fig. 1. Overview of in situ hybridisation of CRF1 mRNA in the brain of Xenopus laevis, at 
the level of the diencephalon, with various positive regions, with an antisense oligonucleotide 
probe (a), and lack of hybridisation signal with the complementary sense probe (b). Bar = 
100 .^m.
Fig. 2. Schematic sagittal view of the brain of X. laevis. The locations of CRF1 mRNA- 
positive neurones as visualised by in situ are indicated by black dots. Acc, nucleus 
accumbens; Apl, amygdala, pars lateralis; Apm, amygdala, pars medialis; Cb, cerebellum; 
Hv, nucleus habenularis ventralis; igl, internal granule cells of the olfactory bulb; lpd, latero- 
dorsal pallium; lpv, latero-ventral pallium; pd, pituitary gland, pars distalis; pi, pituitary 
gland, pars intermedia; pn, pituitary gland, pars nervosa; Poa, preoptic area; SC, 
suprachiasmatic nucleus; tect, mesencephalic tectum; TP, posterior tubercle; VH, ventral 
hypothalamic nucleus; VM, ventromedial thalamic nucleus.
Fig. 3. Sagittal sections of the brain and pituitary gland of X. laevis, showing CRF1 mRNA 
hybridisation in (a) internal granule cell layer of the olfactory bulb, (b) nucleus accumbens, 
(c) medial part of the amygdala, (d) preoptic area of the hypothalamus (Poa), suprachiasmatic 
nucleus (Sc), (e) ventromedial thalamic nucleus, (f) ventral hypothalamic area, (g) tectum 
mesencephali, and (h) cerebellum. Bar a,d = 50 .^m; b,c,e-h = 20 .^m.
Fig. 4. CRF1 mRNA in the pituitary gland of X. laevis. In the melanotrope cells in the pars 
intermedia (pi) hybridisation is weak in a black-adapted animal (a, detail in c) but strong in a 
white-adapted one (b, detail in d). In the pars nervosa (pn) no signal is present (a). Only some 
cells of the pars distalis (pd) show a positive hybridisation signal (e). Bar a,b = 50 .^m; bar c 
= 30; bar d-f = 20 .^m.
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1
2
3
4 Fig. 5. Effect of background adaptation on the OD expressed as arbitrary units (a.u.) of CRFi
5
6 in situ hybridisation signals in internal granule cell layer of the olfactory bulb (igl), distal
7
8 (pd) and intermediate lobe (pi) of the pituitary gland. White bars indicate white-adapted and
9
10 black bars black-adapted Xenopus. Values are expressed as means ± standard error of the
11
12 mean. Asterisk indicates significant difference between the two adaptation states (*P<0.05).
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Table 1. Distribution of xCRF1 mRNA, CRF- and Ucn1-ir cells and fibres in the X. laevis 
brain and pituitary gland, as visualised by in situ hybridisation and immunocytochemistry, 
according to Yao [27] and Calle [28]. For the in situ hybridisation, ratings reflect the intensity 
of positively labelled cells, with (+) indicating a low, (++) moderate and (+++) strong 
intensity of the staining; for immunocytochemistry the number of positive cells is indicated 
as follows: (+) rare, (++) some and (+++) numerous. Immunoreactive fibres are indicated by 
(+), (-) indicates a complete lack of labelling; s.d. stimulus-dependent staining.
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BRAIN REGION CRF1
mRNA
CRF-ir 
refs [27,28]
Ucn1-ir 
ref. [27]
Telencephalon
Olfactory bulb, internal granule cells (igl) +++
Cells
+
Fibres
+
Cells Fibres
+
Mitral cell layer (ml) - ++ + - -
Medial olfactory tract (mot) - - - - +
Post-olfactory eminence (pe) - ++ - - -
Medial septum (ms) - - + - +
Lateral septum (ls) - - ++ - -
Latero-dorsal/ventral pallium (lpd, lpv) ++ - + - -
Dorsal pallium (dp) - - + - +
Medial pallium (mp) - - + - -
Striatum (Str) - + - - +
Accumbens (Acc) ++ +++ + - +
Diagonal band of Broca (DB) - - + - +
Amygdala pars medialis (Apm) + + + - -
Amygdala pars lateralis (Apl) + ++ + - -
Anterior commissure (ac) - - + - -
Diencephalon
Preoptic area (Poa) ++ ++ + - -
Nucleus habenularis ventralis (Hv) ++ +++ - - -
Ventromedial thalamic nucleus (VM) ++ + - - -
Anterior thalamic nucleus (A) - + - - +
Central thalamic nucleus (C) - - - - +
Posterior thalamic nucleus (P) - - - - +
Magnocellular nucleus, medial part (Mgm) - ++ + ++ +
Magnocellular nucleus, ventral part (Mgv) - ++ + +++ +
Magnocellular nucleus, dorsal part (Mgd) - - - - -
Suprachiasmatic nucleus (SC) ++ + + - -
Paraventricular organ (NPv) - ++ + - -
Posterior tubercle (TP) + + + - +
Ventral hypothalamic nucleus (VH) +++ + + - -
Median eminence zona interna (zi) - - + - +
Median eminence zona externa (ze) - - + - +
Pituitary pars nervosa (pn) - - + - +
Pituitary pars intermedia (pi) s.d. - - - -
Pituitary pars distalis (pd) ++ - - - -
Mesencephalon
Tectum mesencephali (tect) ++ +++ + - +
Tegmentum mesencephali (tegm) - - + - +
Edinger-Westphal nucleus (EW-N) - - + +++ +
Anterior tegmental nucleus (Av, Ad) - ++ + - -
Posterior commissure (pc) - - + - -
Nucleus posteroventralis tegmenti (pv) - + - ++ -
Torus semicircularis (Tor) - - + - +
Rhombencephalon - - - - -
Cerebellum (Cb) +++ - + - -
Locus coeruleus (Lc) - ++ + - -
Central gray (cg) - - - ++ -
Nucleus reticularis medius (Rm) - - - + -
Cochlear nucleus (LL) - - - - +
Nucleus motorius nervi trigemini (Vm) - ++ + ++ -
Nucleus motorius of the facial and - - - ++ +
glossopharingeal nerve (IX) 
Nucleus motorius nervi vagi (Xm) - - - ++ -
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Overview of in situ hybridisation of CRF1 mRNA in the brain of Xenopus laevis, at the level 
of the diencephalon, with various positive regions, with an antisense oligonucleotide 
probe (a), and lack of hybridisation signal with the complementary sense probe (b). Bar
= 100 ^ m.
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Schematic sagittal view of the brain of X. laevis. The locations of CRF1 mRNA-positive 
neurones as visualised by in situ are indicated by black dots. Acc, nucleus accumbens; 
Apl, amygdala, pars lateralis; Apm, amygdala, pars medialis; Cb, cerebellum; Hv, nucleus 
habenularis ventralis; igl, internal granule cells of the olfactory bulb; lpd, latero-dorsal 
pallium; lpv, latero-ventral pallium; pd, pituitary gland, pars distalis; pi, pituitary gland, 
pars intermedia; pn, pituitary gland, pars nervosa; Poa, preoptic area; SC, 
suprachiasmatic nucleus; tect, mesencephalic tectum; TP, posterior tubercle; VH, ventral 
hypothalamic nucleus; VM, ventromedial thalamic nucleus.
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Sagittal sections of the brain and pituitary gland of X. laevis, showing CRF1 mRNA 
hybridisation in (a) internal granule cell layer of the olfactory bulb, (b) nucleus 
accumbens, (c) medial part of the amygdala, (d) preoptic area of the hypothalamus 
(Poa), suprachiasmatic nucleus (Sc), (e) ventromedial thalamic nucleus, (f) ventral 
hypothalamic area, (g) tectum mesencephali, and (h) cerebellum. Bar a,d = 50  ^m;
b,c,e-h = 20  ^m.
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CRF1 mRNA in the pituitary gland of X. laevis. In the melanotrope cells in the pars 
intermedia (pi) hybridisation is weak in a black-adapted animal (a, detail in c) but strong 
in a white-adapted one (b, detail in d). In the pars nervosa (pn) no signal is present (a). 
Only some cells of the pars distalis (pd) show a positive hybridisation signal (e). Bar a,b
= 50  ^m; bar c = 30; bar d-f =20  ^m.
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Effect of background adaptation on the OD expressed as arbitrary units (a.u.) of CRFi in 
situ hybridisation signals in internal granule cell layer of the olfactory bulb (igl), distal 
(pd) and intermediate lobe (pi) of the pituitary gland. White bars indicate white-adapted 
and black bars black-adapted Xenopus. Values are expressed as means ± standard error 
of the mean. Asterisk indicates significant difference between the two adaptation states
(*P<0.05).
